about
La autoantigen is required for the internal ribosome entry site-mediated translation of Coxsackievirus B3 RNA.Mycophenolate mofetil inhibits the development of Coxsackie B3-virus-induced myocarditis in miceIncreased Echogenicity and Radiodense Foci on Echocardiogram and MicroCT in Murine MyocarditisBerberine Restricts Coxsackievirus B Type 3 Replication via Inhibition of c-Jun N-Terminal Kinase (JNK) and p38 MAPK Activation In Vitro.Enteroviruses as a possible cause of hypertension, dilated cardiomyopathy (DCM) and hypertensive heart failure (HHF) in South western Nigeria.5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.Identification of a novel antigen-presenting cell population modulating antiinfluenza type 2 immunity.Cardiac myosin and the TH1/TH2 paradigm in autoimmune myocarditisStructure and dynamics of coxsackievirus B4 2A proteinase, an enyzme involved in the etiology of heart diseaseShort hairpin RNA targeting 2B gene of coxsackievirus B3 exhibits potential antiviral effects both in vitro and in vivo.Interferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice.Replication of coxsackievirus B3 in primary cell cultures generates novel viral genome deletionsCoxsackievirus B3, Shandong Province, China, 1990-2010.Molecular Analysis of RNA-RNA Interactions between 5' and 3' Untranslated Regions during the Initiation of Translation of a Cardiovirulent and a Live-Attenuated Coxsackievirus B3 StrainsA critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity.Pathogenesis of coxsackievirus-B5 acquired from intra-renal porcine islet cell xenografts in diabetic mice.Expression of an antigenic adenovirus epitope in a group B coxsackievirus.The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injuryThe interferon inducer ampligen [poly(I)-poly(C12U)] markedly protects mice against coxsackie B3 virus-induced myocarditisA genetically engineered attenuated coxsackievirus B3 strain protects mice against lethal infection.Connecting enterovirus infection to dystrophin dysfunction in dilated cardiomyopathy.
P2860
Q24537667-AF5A6C17-0C4B-41AA-A8BA-B3FCD5F7A21DQ24804882-F5229C17-FAF0-441B-BF43-E359B3D0795CQ27332440-00EEAB85-BD19-4D16-BA03-6EE872D2D042Q33557579-578C7AD5-20DE-4E08-B2C1-95622FDEA073Q33751633-A34BEE6C-2C06-4B04-933A-1C793E5169CCQ33788804-23540D4E-8B1E-4591-9CB4-42C40A4FDCB0Q33979910-5FEED212-3D65-4ADF-9453-CFE33D4FBC65Q34299695-9983BD73-99F9-4545-ABFB-A83A656D3459Q34302090-47898F20-1A69-48B3-BF66-CF381CFA961DQ34366003-B698978C-820E-4D58-89A9-7D16B5911005Q35915997-D5E59F22-7066-4DC6-8DF3-288782CE2D03Q36483302-524FC0CE-5479-4C79-8468-6029957BC972Q36574263-7DE0966A-869D-44D0-AE82-7777B1AA8D38Q36790304-D0187732-2AC4-4382-8C8E-3EED26EB96D6Q37068653-AF2DEA24-6868-4C7E-A747-7A7C6902AB67Q37337072-225DBF75-7CDE-44A5-9304-E3F650110D9CQ39591041-5967DAB7-2CD3-4C31-93E7-64B8DFBB5E5FQ39741176-2B3322E6-DC43-46A6-A890-C33546358B9BQ40410470-35967DAC-8CAA-447E-B5E6-B75EAC02AF29Q41897207-110C8569-552C-43BA-8984-FAFDFD212160Q42370356-37DB48C1-8C7C-4E48-B14A-1C55AF3FE8B2
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Coxsackie B viruses and human heart disease.
@en
type
label
Coxsackie B viruses and human heart disease.
@en
prefLabel
Coxsackie B viruses and human heart disease.
@en
P2093
P1476
Coxsackie B viruses and human heart disease
@en
P2093
C Baboonian
M J Davies
W J McKenna
P356
10.1007/978-3-642-60687-8_3
P577
1997-01-01T00:00:00Z